ClinConnect ClinConnect Logo
Search / Trial NCT00923065

Data Collection, Clinical Care and Interventions in CCR, NCI

Launched by NATIONAL CANCER INSTITUTE (NCI) · Jun 17, 2009

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Cancer Natural History

ClinConnect Summary

Background:

* Clinical Investigators within the Center for Cancer Research (CCR) at the National Cancer Institute (NCI) evaluate and treat patients with cancer, HIV, and individuals at risk for developing cancer in the context of active research protocols.
* In some cases, it may be in the best interests of both the individual and the CCR to provide consult services, treatment/interventions, and/or follow-up to certain individuals and collect the data obtained for future research.

Objectives:

-To provide a repository of information on enrolled participants to allow for hypothesis generat...

Gender

ALL

Eligibility criteria

  • * INCLUSION CRITERIA:
  • Individuals must be age 2 years or older if therapeutic interventions are required. Otherwise, there are no age restrictions beyond the neonatal period (4 weeks).
  • * Individuals will be eligible if they meet one of the following criteria:
  • are seeking a consultation from NCI/CCR.
  • whose medical welfare will be seriously compromised by referral back to the community, such as rare/complex diseases in which community treatment is inadequate or adequate community resources are unavailable.
  • have cancer, HIV, or are at risk for cancer and/or HIV for whom cancer evaluation, treatment or management at the NCI is requested.
  • who will serve or have served as cellular therapy donors, for the treatment of a recipient of cellular therapy on an NCI trial.
  • are participants or biologic family members of deceased participants, where genetic testing is required or a clinically actionable germline pathogenic or likely pathogenic variant with medical implications was discovered by a research laboratory that requires CLIA confirmation. Note: In some cases, enrollment onto this study is also necessary when the prior study on which the involved participant was originally enrolled is closed and/or the participant is now off study.
  • The individual or their Legally Authorized Representative is able and willing to provide informed consent.
  • EXCLUSION CRITERIA:
  • None

About National Cancer Institute (Nci)

The National Cancer Institute (NCI) is a prominent component of the National Institutes of Health (NIH), dedicated to advancing cancer research and improving patient outcomes through innovative clinical trials. As a leading sponsor of cancer-related studies, NCI focuses on facilitating the development of new therapies, enhancing prevention strategies, and understanding the biology of cancer. The institute collaborates with academic institutions, healthcare providers, and industry partners to conduct rigorous clinical trials that aim to translate scientific discoveries into effective treatments. NCI’s commitment to fostering a robust research environment supports the mission to eliminate cancer as a major health problem.

Locations

Bethesda, Maryland, United States

Patients applied

0 patients applied

Trial Officials

Fatima H Karzai, M.D.

Principal Investigator

National Cancer Institute (NCI)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials